A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy
Clinical trial NCT06356675 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06356675
- Sponsor
- The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.